Universal Technical Institute, Inc. (UTI)

Universal Technical Institute, Inc. has experienced a stock price increase of 103.85% in the past six months. The company's Q2 CY2025 results exceeded market expectations, with revenue up 15.1% year-on-year and GAAP EPS significantly above estimates. Analysts have given UTI a consensus rating of "Moderate Buy," with an average 1-year price objective of $35.83.

Universal Technical Institute operates on a continuous enrollment model rather than a traditional term-based system. Classes are not conducted on a term basis, and enrollment can occur at any time throughout the year. New instruction periods for UTI classes are scheduled approximately every six weeks, indicating that demand is not strictly seasonal.

Universal Technical Institute, Inc. (UTI) is a workforce solutions provider specializing in transportation, skilled trades, and healthcare education programs. The company offers degree and non-degree technical training programs through two segments: Universal Technical Institute (UTI) and Concorde Career Colleges. The UTI segment provides training for various technician roles and welding technology, while the Concorde segment focuses on allied health and related fields.

Universal Technical Institute has a significant presence across the United States. The UTI segment operates 16 campuses in nine states, and Concorde Career Colleges operates 17 campuses in eight states and online. Specific campus locations include Bloomfield, New Jersey, Sacramento, California, and Exton, Pennsylvania. UTI has also expanded its training programs to U.S. military bases.

The brand reputation of Universal Technical Institute appears to be mixed. While the institution provides hands-on training, concerns exist regarding the cost and academic transferability of its programs. Graduates typically receive a diploma, and the associate's degree may not be easily transferable to other schools.

Universal Technical Institute, Inc. has a diverse ownership structure including institutional, retail, and individual investors. Institutional investors hold a significant portion of the company's stock. Major institutional owners include Vanguard Group Inc, BlackRock, Inc., and Coliseum Capital Management, LLC. Individual insiders hold a smaller percentage of the stock, while the general public and retail investors hold the remaining shares.